Table 1: Skipping percentages following Vivo-Morpholino treatment.

Skipped dystrophin transcripts as a percentage of total dystrophin transcripts in diaphragms and body walls from mdx mice treated with Vivo-Morpholinos (as indicated). NTX: no treatment; Skip only: M23D skipping oligo alone; skip+pro: M23D combined with protector; skip+scram: M23D combined with scrambled protector sequence. Means + SEM (N=6 –same sample groups as in figure 4)

	Body wall (%)	Diaphragm (%)
NTX	0.43±0.1	1.1±0.1
Skip Only	8.9±1.3	21.6±2.5
Skip + Pro	18.0±3.9	21.8±1.8
Skip + Scram	20.5±5.3	24.0±1.9